M. Leach et al., Autoimmune thrombocytopenia: A complication of fludarabine therapy in lymphoproliferative disorders, CLIN LAB H, 22(3), 2000, pp. 175-178
We describe two cases of autoimmune thrombocytopenia precipitated by fludar
abine therapy in patients with chronic lymphatic leukaemia. Both were treat
ed with high dose steroids and initially responded with recovery of normal
platelet counts. One patient developed recurrent autoimmune thrombocytopeni
a on two occasions following re-exposure to the drug when his disease had b
ecome refractory to all other treatments. A retrospective review of the cas
e notes of 45 patients with lymphoproliferative disorders treated with flud
arabine over the past 6 years indicated the development of autoimmune throm
bocytopenia in 4.5% (two out of 45) and autoimmune haemolytic anaemia in 6.
7% (three of the 45).